BOSTON PHARMA OFFICIALLY LICENSED FOR LAUNCHING PRODUCT MOLRAVIR 400 (ACTIVE INGREDIENTS MOLNUPIRAVIR)

On the afternoon of February 17, 2022, the Drug Administration of Vietnam, the Ministry of Health issued an emergency license for 3 drugs containing the active ingredient molnupiravir, designated for the treatment of Covid-19 manufactured by a Vietnamese enterprise.

The product Molravir 400 (active ingredient Molnupiravir 400mg) is officially licensed for circulation in Vietnam by the Ministry of Health.

• Colour hard capsules (The same form as the brand name) - Preventing from direct light.
• Alu-Alu for blister packaging - Environmental factors resistance (Light, Humidity).
• Reasonable and stable price - Transparent at Boston Sale app.
• Ensure adequate product supply.

Molnupiravir is an active ingredient with antiviral effects, considered an important "weapon" in the treatment of F0 at home. The drug works to reduce viral levels when used in the early stages of the disease, thereby reducing the risk of seriousness and death.

Drugs in hard capsule form, for oral administration, are widely sold at drugstores nationwide, convenient for F0 treatment at home.

Carefully read the instructions for use specified in the prescription before use..

Source: Baomoi.com | Thanhnien.vn | Vtc.vn